|
|
| (7 intermediate revisions by the same user not shown) |
| Line 13: |
Line 13: |
|
| |
|
| ==[[Anaphylaxis overview|Overview]]== | | ==[[Anaphylaxis overview|Overview]]== |
|
| |
| There is no established system for the classification of [disease name].
| |
|
| |
| OR
| |
|
| |
| [Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
| |
|
| |
| OR
| |
|
| |
| [Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
| |
|
| |
| OR
| |
|
| |
| Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
| |
|
| |
| OR
| |
|
| |
| If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
| |
|
| |
| OR
| |
|
| |
| The staging of [malignancy name] is based on the [staging system].
| |
|
| |
| OR
| |
|
| |
| There is no established system for the staging of [malignancy name].
| |
|
| |
|
| ==[[Anaphylaxis historical perspective|Historical Perspective]]== | | ==[[Anaphylaxis historical perspective|Historical Perspective]]== |
|
| |
| Discovery
| |
| There is limited information about the historical perspective of [disease name].
| |
| OR
| |
|
| |
| [Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
| |
| The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
| |
| In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
| |
| In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
| |
|
| |
|
| ==[[Anaphylaxis classification|Classification]]== | | ==[[Anaphylaxis classification|Classification]]== |
|
| |
| There is no established system for the classification of [disease name].
| |
|
| |
| OR
| |
|
| |
| [Disease name] may be classified according to [classification method] into [number] subtypes/groups:
| |
|
| |
| [Group1]
| |
| [Group2]
| |
| [Group3]
| |
| [Group4]
| |
| OR
| |
|
| |
| [Disease name] may be classified into [large number > 6] subtypes based on:
| |
|
| |
| [Classification method 1]
| |
| [Classification method 2]
| |
| [Classification method 3]
| |
| [Disease name] may be classified into several subtypes based on:
| |
|
| |
| [Classification method 1]
| |
| [Classification method 2]
| |
| [Classification method 3]
| |
| OR
| |
|
| |
| Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
| |
|
| |
| OR
| |
|
| |
| If the staging system involves specific and characteristic findings and features:
| |
|
| |
| According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
| |
|
| |
| OR
| |
|
| |
| The staging of [malignancy name] is based on the [staging system].
| |
|
| |
| OR
| |
|
| |
| There is no established system for the staging of [malignancy name].
| |
|
| |
|
| ==[[Anaphylaxis pathophysiology|Pathophysiology]]== | | ==[[Anaphylaxis pathophysiology|Pathophysiology]]== |
|
| |
| {{CMG}}; {{AE}}
| |
| ==Overview==
| |
| The exact pathogenesis of [disease name] is not fully understood.
| |
|
| |
| OR
| |
|
| |
| It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
| |
|
| |
| OR
| |
|
| |
| [Pathogen name] is usually transmitted via the [transmission route] route to the human host.
| |
|
| |
| OR
| |
|
| |
| Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
| |
|
| |
| OR
| |
|
| |
|
| |
| [Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
| |
|
| |
| OR
| |
|
| |
| The progression to [disease name] usually involves the [molecular pathway].
| |
|
| |
| OR
| |
|
| |
| The pathophysiology of [disease/malignancy] depends on the histological subtype.
| |
|
| |
| ==Pathophysiology==
| |
| ===Physiology===
| |
| The normal physiology of [name of process] can be understood as follows:
| |
|
| |
| ===Pathogenesis===
| |
| *The exact pathogenesis of [disease name] is not completely understood.
| |
| OR
| |
| *It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
| |
| *[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
| |
| *Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
| |
| *[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
| |
| *The progression to [disease name] usually involves the [molecular pathway].
| |
| *The pathophysiology of [disease/malignancy] depends on the histological subtype.
| |
|
| |
| ==Genetics==
| |
| [Disease name] is transmitted in [mode of genetic transmission] pattern.
| |
|
| |
| OR
| |
|
| |
| Genes involved in the pathogenesis of [disease name] include:
| |
| *[Gene1]
| |
| *[Gene2]
| |
| *[Gene3]
| |
|
| |
| OR
| |
|
| |
| The development of [disease name] is the result of multiple genetic mutations such as:
| |
|
| |
| *[Mutation 1]
| |
| *[Mutation 2]
| |
| *[Mutation 3]
| |
|
| |
| ==Associated Conditions==
| |
| Conditions associated with [disease name] include:
| |
|
| |
| *[Condition 1]
| |
| *[Condition 2]
| |
| *[Condition 3]
| |
|
| |
| ==Gross Pathology==
| |
| On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
| |
|
| |
| ==Microscopic Pathology==
| |
| On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
| |
|
| |
|
| ==[[Anaphylaxis causes|Causes]]== | | ==[[Anaphylaxis causes|Causes]]== |
| Line 180: |
Line 31: |
|
| |
|
| ==Diagnosis== | | ==Diagnosis== |
| [[Anaphylaxis diagnostic study of choice|Diagnostic study of choice]] | [[Anaphylaxis history and symptoms|History and Symptoms]] | [[Anaphylaxis physical examination|Physical Examination]] | [[Anaphylaxis laboratory findings|Laboratory Findings]] | [[Anaphylaxis Electrocardiogram| Electrocardiogram]] | [[Anaphylaxis chest x ray|Chest X Ray]] | [[Anaphylaxis other diagnostic studies|Other Diagnostic Studies]]
| | [[Anaphylaxis history and symptoms|History and Symptoms]] | [[Anaphylaxis physical examination|Physical Examination]] | [[Anaphylaxis laboratory findings|Laboratory Findings]] | [[Anaphylaxis chest x ray|Chest X Ray]] | [[Anaphylaxis other diagnostic studies|Other Diagnostic Studies]] |
|
| |
|
| ==Treatment== | | ==Treatment== |
